Welcome to Consumer Reports Advocacy

For 85 years CR has worked for laws and policies that put consumers first. Learn more about CR’s work with policymakers, companies, and consumers to help build a fair and just marketplace at TrustCR.org

Potential Public Health Impacts Of The Use Of Recombinant Bovine Somatotropin In Dairy Production-Part 2-References

September 1997
References – Potential Public Health Impacts Of The Use Of Recombinant Bovine Somatotropin In Dairy Production
Baserga, R. 1995. The role of insulin-like growth factor 1 receptor in cell growth and transformation, pp. 54-55. In: LeRoith D., moderator. Insulin-like growth factors and cancer. Annals of Internal Medicine, 122: 54-59.
Baumrucker, R.R. and J.W. Blum. 1993. Secretion of insulin-like growth factors in milk and their effect on the neonate. Livestock Production Sciences, 35: 49-72.
—————–, Hadsell, D.J., Skarr, T.C., Campbell, P.G., and J.W. Blum. 1992. Insulin-like growth factors (IGFs) and IGF binding proteins in mammary secretions: origins and implications in neonatal physiology. Pp. 285-308 In Mechanisms Regulating Lactation and Infant Nutrient Utilization. M.F. Picciano, B. Lonnerdal, (Eds.). New York, Wiley-Liss.
Beekes, M., Baldauf, E. and H. Diringer. 1996. Sequential appearance and accumulation of pathognomonic markers in the central nervous system of hamsters orally infected with scrapie. Journal of General Virology, 77: 1925-1934.
Berger, J.R., Weisman, E. and B. Weisman. 1997. Creutzfeldt-Jakob disease and eating squirrel brains. The Lancet August 30, 1997.
Blakeslee, S. 1997. Kentucky doctors warn against a regional dish: squirrels’ brains. New York Times. August 29, 1997, pg. A10.
Blättler, T., S. Bradner, A.J. Raeber, M.A. Klein, T. Volgtländer, C. Weissmann and A. Aguzzi. 1997. Prp-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature, 389: 69-73.
Bobowick, A.R., Brody, J.A., Matthews, M.R., Roos, R. and D.C. Gajdusek. 1973. Creutzfeldt-Jakob disease: A case-control study. American Journal of Epidemiology 98: 381-394.
Brady, M.S., White, N. and S.E. Katz. 1993. Resistance development potential of antibiotic/antimicrobial residue levels designated as “safe levels.” Journal of Food Protection, 56(3): 229-233.
Brandner, S., Raeber, A., Sailer, A., Blättler, T., Fischer, M., Weissmann and A. Aguzzi. 1996. Normal host prion protein (PrPc) required for scrapie spread within the central nervous system. Proceedings of the National Academy of Sciences, 93: 13148-13151.
Brunner, J.E., Johnson, C.C., Zafar, S., Peterson, E.L., Brunner, J.F., and R. C. Mellinger. 1990. Colon cancer and polyps in acromegaly: Increased risk associated with family history of colon cancer. Clinical Endocrinology, 32: 65-71.
Challacombe, D.N. and E.E. Wheeler. 1994. Safety of milk from cows treated with bovine somatotropin. The Lancet, 344: 815-816.
Coghlan, A. 1994. Arguing till the cows come home. New Scientist, October 29: pp. 14-15.
Coleman, M.R., Ghrist, B.F.D., Mowrey, D.H., McGuffey, R.K., and J.C. Kube. 1990. Determination of insulin-like growth factor (IGF-I) concentrations in raw milk from non-supplemented animals and in raw, pasteurized and heat-treated milk from animals supplemented with somidobove. Unpublished study T4U709001, Elanco Animal Health, Greenfield, NJ.
Consumers Union. 1997. Consumers Union’s Comments on Docket No. 96N-0135, Substances Prohibited for Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed, Draft Rule. April 28, 1997. 8 pp.
Corps, A.N. and K.D. Brown. 1987. Stimulation of intestinal epithelial cell proliferation in culture by growth factors in human and ruminant mammary secretions. Journal of Endocrinology, 113: 285-290.
Craven, N. 1991. Milk production and mastitis susceptibility: genetic relationships and influence of bovine somatotropin treatment. Pp. 55-59. In: J. Espinasse (Ed.) Mammites des Vaches Laitieres. Toulouse, France: Polygone,.
Davanipour, Z., Alter, M., Sobel, E., Asher, D.M. and D.C. Gajdusek. 1985. A case-control study of Creutzfeldt-Jakob disease: Dietary risk factors. American Journal of Epidemiology 122: 433-451.
Davis, S.R., Gluckman, P.D., and Bryant, A.M. 1989. Effects of somidobove treatment of dairy cows on plasma and milk concentrations of insulin-like growth factor-I. Unpublished Elanco report, Ruakura Agricultural Centre, Hamilton, New Zealand.
Devesa, S.S., Blot, W.J., Miller, B.J. Stone, B.A., Tarone, R.E. and J.F. Fraumeni, Jr. 1995. Recent cancer trends in the United States. Journal of the National Cancer Institute, 87(3): 175-182.
Doi, M., Matzner, N.D. and C. Rothaug. 1979. Observation of CNS disease in market hogs at Est. 893 – Tobin Packing Co., Inc. Albany, New York. United States Department of Agriculture, Food Safety and Quality Service, Meat and Poultry Inspection Service. 7pp.
Donovan, S.M., and J. Odle. 1994. Growth factors in milk as mediators of infant development. Annual Review of Nutrition, 14: 147-167.
Epstein, S. 1996. Unlabeled milk from cows treated with biosynthetic growth hormones: A case of regulatory abdication. International Journal of Health Services, 26(1): 173-185.
Ezzat, S., and S. Melmed. 1991. Clinical Review 18. Are patients with acromegaly at increased risk for neoplasia? Journal of Clinical Endocrinology and Metabolism, 72(2): 245-249.
Ezzat, S., C. Strom, and S. Melmed. 1991. Colon polyps in acromegaly. Annals of Internal Medicine, 114: 754-755.
Food and Agriculture Organization of the United Nations (FAO). 1993. Residues of some veterinary drugs in animals and foods, Bovine Somatotropins. FAO, 41/5: 113-142.
Food and Drug Administration (FDA). 1993. Freedom of Information Summary. POSILAC (sterile sometribove zinc suspension) For increasing production of marketable milk in lactating dairy cows. November, 1993. 130+ pp.
Fraser, H. and A.G. Dickinson. 1978. Studies of the lymphoreticular system in the pathogenesis of scrapie: the role of spleen and thymus. Journal of Comparative Pathology, 88: 563-573.
Gajdusek, D.C. 1993. Genetic control of nucleation and polymerization of host precursors to infectious amyloids in the transmissible amyloidoses of brain. British Medical Bulletin, 49: 913-931.
GAO, 1990. Food Safety and Quality: FDA Surveys Not Adequate to Demonstrate Safety of Milk Supply. GAO/RCED-91-26. 40 pp.
———1992. Food Safety and Quality: FDA Strategy Needed to Address Animal Drug Residues in Milk. GAO/RCED-92-209. 64 pp.
Gibbs, C.J., Safar, J., Ceroni, M., Di Martino, A., Clark, W.W. and J.L. Hourrigan. 1990. Experimental transmission of scrapie to cattle. Lancet, 335: 1275.
————– 1997. Statement to the Committee on Government Reform and Oversight, Subcommittee on Human Resources and Intergovernmental Relations, U.S. House of Representatives. January 29, 1997.
Groschup, M.H., F. Weiland, O.C. Straub, and E. Pfaff. 1996. Detection of scrapie agent in the peripheral nervous system of a diseased sheep. Neurobiology of Disease, 3: 191-195.
Hadlow, W.J. 1997. Letter to Patrick McCaskey, USDA/FSIS/Eastern Lab, dated April 1, 1997.
Hansen, M. 1993. Letter to Jerry Mande, FDA, dated May 24, 1993.
Helman, L. 1995. The role of insulin-like growth factors in rhabdomyosarcomas and osteosarcomas. In: LeRoith D, moderator. Insulin-like growth factors and cancer. Annals of Internal Medicine, 122: 54-59.
Honegger, A. and R.E. Humbel. 1986. Insulin-like growth factors I and II in fetal and adult bovine serum–purification, primary structures, and immunological cross-reactivities. The Journal of Biological Chemistry, 261(2): 569-575.
Hoppener, J.W.M., S. Mosselman, P.J.M. Roholl, C. Lambrechts, R.J.C. Slebos, P. de Pagter-Holthuizen, C.J.M. Lips, H.S. Jansz, and J.S. Sussenbach. 1988. Expression of insulin-like growth factor-I and II genes in human smooth muscle tumours. EMBO Journal, 7: 1379-1385.
Ituarte, E.A., J. Petrini, and J.M. Hersman. 1984. Acromegaly and colon cancer. Annals of Internal Medicine, 101: 627-628.
Juskevich, J.C., and C.G. Guyer. 1990. Bovine growth hormone: human food safety evaluation. Science, 249: 875-884.
Juul, A., Main, K., Blum, W.F., Lindholm, J., Ranke, M.B. and N.E. Skakkebæk. 1994. The ratio between serum levels of IGF-1 and the IGF binding proteins decreases with age in healthy patients and is increased in acromegalic patients. Clinical Endocrinology, 41: 85-93.
Klein, I., Parveen, G., Gavaler, J.S., and D.H. Vanthiel. 1982. Colonic polyps in patients with acromegaly. Annals of Internal Medicine, 97: 27-30.
Koldovsky, O., Philips, A., Rao, R.K. and P. Schaudies. 1992. Possible role of milk-borne peptide growth factors for the breast-fed infant. Pp. 150-169 In Regulatory Gut Peptides in Paediatric Gastroenterology and Nutrition. P. Heinz-Erian, J. Deutsch, G. Granditsch, (Eds.).
Kronfeld, D.S. 1994. Health management of dairy herds treated with bovine somatotropin. Journal of the American Veterinary Medical Association, 204(1): 116-130.
———————1997. Rekombinant bovint somatotropin: Synpunkter på informations-och djurhälsoetik (Recombinant bovine somatotropin: Ethics of communication and animal welfare). Svensk Veterinä tidning, 49(4): 157-165.
Laburthe, M., Rouyer-Fessard, C., and S. Gammeltoft. 1988. Receptors for insulin-like growth factors I and II in rat gastrointestinal epithelium. American Journal of Physiology, 254: G457-462.
Lahm, H., Suardet, L., Laurent, P.L., Fischer, J.R., Ceyhan, A., Givel, J.-C. and N. Odartchenko. 1992. Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha. British Journal of Cancer 65(3): 41-346.
Langheinrich, K.A. 1979. USDA/FSQS Laboratory report on specimen 2709. Dated November 8, 1979.
Lasmézas, C., Deslys, J.P. and D. Dormont. 1993. Recombinant human growth hormone and insulin-like growth factor 1 induce PRP gene expression in PC12 cells. Biochemical and Biophysical Research Communications, 196(3): 1163-1169.
LeRoith, D. 1995. Insulin-like growth factors and breast cancer. In: LeRoith D, moderator. Insulin-like growth factors and cancer. Annals of Internal Medicine, 122: 54-59.
Lippman, M. 1991. Growth factors, receptors and breast cancer. Journal of National Institutes on Health Res., 3: 59-62.
Macaulay, V.M. 1992. Insulin-like growth factors and cancer. British Journal of Cancer, 65: 311-320.
MacKenzie, D. 1997. Secrets and lies in Europe. New Scientist, May 3, 1997. Pp. 14-15.
Miller, M.A., Hildebrandt, J.R., White, T.C., Hammond, B.G., Madsen, K.S. and R.J. Collier. 1989. Determinations of IGF-I concentrations in raw, pasteurized, and heat-treated milk. Unpublished report MSL 8673 dated January 3, 1989, Monsanto Agricultural Company, St. Louis, MO.
Monsanto, 1993. Technical manual for Posilac. Monsanto Co., St. Louis.
National Institutes of Health (NIH). 1991. Technology assessment conference statement on bovine somatotropin. Journal of the American Medical Association, 265: 1423-1425.
Olanrewaju, H., Patel, L., and E.R. Siedel. 1992. Trophic action of local intraileal infusion of insulin-like growth factor 1: Polyamine dependence. American Journal of Physiology, 263: E282-E286.
Osborne, C. 1991. Memo entitled Bovine Spongiform Encephalopathy: CVM Options for Control and Prevention, dated July 3, 1991. 7 pp.
Patterson and Millson. 1962. Distribution of the scrapie agent in the tissues of experimentally inoculated goats. Journal of Comparative Pathology and Therapeutics, 72: 233-244.
Pavelic, J., D. Vrbanec, S. Marusic, S. Levanat, and T. Cabrijan. 1986. Autocrine growth regulation by somatomedin C: an in vitro model. Journal of Endocrinology, 109: 233-238.
Pell, A.N., Tsang, D.S., Howlett, B.A., Huylet, M.T., Meserole, V.K., Samuels, W.A., Hartnell, G.F., and R.L. Hintz. 1992. Effects of a prolonged-release formulation of sometribove (n-Methionyl Bovine Somatotropin) on Jersey cows. Journal of Dairy Sciences, 75: 3416-3431.
Phillips, A.F., Rao, R., McCracken, D., and O. Koldovsky. 1990. Presence of insulin-like growth factor-I (IGF-I) in rat milk and the absorption of IGF-I by the suckling rat. Pediatric Research, 27: 49.
Pines, A., Rosen, P., Ron, E., and T. Gilat. 1985. Gastrointestinal tumors in acromegalic patients. The American Journal of Gastroenterology, 80(4): 266-269.
Playford, R.J., et. al. 1993. Effect of luminal growth factor preservation on intestinal growth. Lancet 2: 843-848.
Prosser, C.G., Fleet, I.R., and A.N. Corps. 1989. Increased secretion of insulin-like growth factor I into milk of cows treated with recombinantly derived bovine growth hormone. Journal of Dairy Research, 56: 17-26.
Prusiner, S.B. 1991. Molecular biology of prion diseases. Science, 252: 1515-1522.
——————–1982. Molecular biology of prion diseases. Science, 216: 136.
Rosen, N., D. Yee, M.E. Lippman, S. Paik and J.J. Cullen. 1991. Insulin-like growth factors in human breast cancer. Breast Cancer Research and Treatment, 18: S55-S62.
Rubenstein, R., Scalici, C.L., Papini, M.C., Callahan, S.M. and R.I. Carp. 1990. Further characterization of scrapie replication in PC12 cells. Journal of General Virology, 70: 825-831.
Schams, D., and Karg, H. 1988a. Technical report on BST in dairy cows in 1987. Unpublished Elanco report dated April 19, 1988. Technische Universitat Munchen, Institute of Physiology, D-8050 Freising-Weihenstephan.
————————————-1988b. Technical report on BST in dairy cows in 1988. Unpublished Elanco report dated September 23, 1988. Technische Universitat Munchen, Institute of Physiology, D-8050 Freising-Weihenstephan.
Schingoethe, D.J. and Cleale, R.M. 1989. Effect of stage of lactation, diet composition and daily injections of 10.3 mg BST monomer to mature lactating Holstein cows on concentrations of insulin-like growth factor-I in milk. Unpublished report FD 37-51 dated May 30, 1989, American Cyanamid Company, Princeton, NJ.
Smith, L.E.H, Kopchick, J.J., Chen, W., Knapp, J., Kinose, F., Daley, D., Foley, E., Smith, R.G. and J.M. Schaeffer. 1997. Essential role of growth hormone in Ischemia-induced retinal neovascularization. Science, 276: 1706-1708.
Thomas, J.W., Erdman, R.A., Galton, D.M., et al. 1991. Responses of lactating cows in commercial dairy herds to recombinant bovine somatotropin. Journal of Dairy Science, 74: 945-964.
Thornburg, W., Matrisian, L., Magnun, B. and O. Koldovsky. 1984. Gastrointestinal absorption of epidermal growth factor in suckling rats. American Journal of Physiology, 246: G80-G85.
Torkelson, A.R., Lanza, G.M., Birmingham, B.K., Vicini, J.L., White, T.C., Dyer, S.E., Madsen, K.S., and Collier, R.J. 1988. Concentrations of insulin-like growth factor 1 (IGF-1) in bovine milk: Effect of herd, stage of lactations, and sometribove, Journal of Dairy Science, 71: 52.
Tremble, J.M., and A.M. McGregor. 1994. Epidemiology, complications and mortality. Journal of Endocrinology Ltd., Bristol, England. Pps. 5-12.
Tricoli, J.V., L.B. Rall, C.P. Karakousis, L. Herrera, J.J. Petrelli, G.I. Bell and T.B. Shows. 1986. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Research, 46: 6169-6173.
Xian, C.J., C.A. Shoubridge and L.C. Read. 1995. Degradation of IGF-I in the adult rat gastrointestinal tract is limited by a specific antiserum or the dietary protein casein. Journal of Endocrinology, 146: 215-225.

Part 1 – Report

1b – Report Continued

2 – References

Part 3 – Tables